Letter: Hyperphosphatemia and hypocalcemia in neoplastic disorders.
D000368:Aged; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002675:Child, Preschool; D002762:Cholecalciferol / Q000378:metabolism; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008223:Lymphoma / Q000097:blood / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D010710:Phosphates / Q000097:blood*; D014527:Uric Acid / Q000097:blood
D000970:Antineoplastic Agents; D010710:Phosphates; D002762:Cholecalciferol; D014527:Uric Acid